p53 polymorphism in human papillomavirus-associated esophageal cancer

被引:1
|
作者
Kawaguchi, H [1 ]
Ohno, S
Araki, K
Miyazaki, M
Saeki, H
Watanabe, M
Tanaka, S
Sugimachi, K
机构
[1] Kyushu Univ, Fac Med, Dept Surg 2, Fukuoka 8128582, Japan
[2] Kyushu Univ Hosp, Ctr Canc, Fukuoka 8128582, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Human papillomavirus type 16/18 (HPV-16/18) is implicated in the pathogenesis of squamous cell carcinoma (SCC) of the cervix and esophagus, The arginine allele at codon 72 of p53 was found to be more susceptible to degradation by HPV E6 protein than is the proline allele in vivo, thus resulting in a high frequency of cervical SCC in individuals homozygous for arginine at the codon, There are controversial results from several clinical studies of cervical SCC, In the present study, encoding regions of p53 codon 72 and HPV-16/18 E6 were directly sequenced, using pairs of primary esophageal SCC tissue and corresponding normal mucosa, which were from 75 patients (Japanese, n = 38; Chinese, n = 37), The arginine allele alone was detected in 70.6% (12 of 17) of HPV-positive cases but only in 43.1% (25 of 58) of HPV-negative cases (P < 0.05). In contrast, such a significant correlation between p53 polymorphism and HPV infection was not evident in corresponding normal mucosae, Because our findings between tumor specimens and the normal mucosae differed, we suggest that the frequent loss of proline allele in HPV-associated carcinogenesis of the esophagus major plays some role, The particular type of p53 polymorphism may indicate a potential candidate for HPV-associated SCC.
引用
收藏
页码:2753 / 2755
页数:3
相关论文
共 50 条
  • [41] Human Papillomavirus-Directed Therapeutics for Human Papillomavirus-Associated Oropharyngeal Cancer
    Campbell, Jean S.
    Pai, Sara, I
    CANCER JOURNAL, 2022, 28 (05): : 407 - 415
  • [42] FREQUENT MUTATION OF THE P53 GENE IN HUMAN ESOPHAGEAL CANCER
    HOLLSTEIN, MC
    METCALF, RA
    WELSH, JA
    MONTESANO, R
    HARRIS, CC
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (24) : 9958 - 9961
  • [43] Treatment preferences in human papillomavirus-associated oropharyngeal cancer
    Windon, Melina J.
    D'Souza, Gypsyamber
    Fakhry, Carole
    FUTURE ONCOLOGY, 2018, 14 (24) : 2521 - 2530
  • [44] Treatment Deintensification for Human Papillomavirus-Associated Oropharyngeal Cancer
    Demetri Arnaoutakis
    Baran D. Sumer
    Annals of Surgical Oncology, 2017, 24 : 3463 - 3465
  • [45] Carcinogenesis and management of human papillomavirus-associated cervical cancer
    Misako Kusakabe
    Ayumi Taguchi
    Kenbun Sone
    Mayuyo Mori
    Yutaka Osuga
    International Journal of Clinical Oncology, 2023, 28 : 965 - 974
  • [46] Immune evasion in human papillomavirus-associated cervical cancer
    Tindle, RW
    NATURE REVIEWS CANCER, 2002, 2 (01) : 59 - 65
  • [47] Treatment Deintensification for Human Papillomavirus-Associated Oropharyngeal Cancer
    Arnaoutakis, Demetri
    Sumer, Baran D.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (12) : 3463 - 3465
  • [48] Human Papillomavirus-Associated Cancers
    Alhamlan, Fatimah S.
    Alfageeh, Mohamed B.
    Al Mushait, Mona A.
    Al-Badawi, Ismail A.
    Al-Ahdal, Mohammed N.
    MICROBIAL PATHOGENESIS: INFECTION AND IMMUNITY, 2ND EDITION, 2021, 1313 : 1 - 14
  • [49] Survivin expression in esophageal cancer: correlation with p53 mutations and promoter polymorphism
    Yang, Xiaoya
    Xiong, Gang
    Chen, Xuedan
    Xu, Xueqing
    Wang, Kai
    Fu, Yong
    Yang, Kang
    Bai, Yun
    DISEASES OF THE ESOPHAGUS, 2009, 22 (03): : 223 - 230
  • [50] Human papillomavirus-associated diseases
    Grce, Magdalena
    Mravak-Stipetic, Marinka
    CLINICS IN DERMATOLOGY, 2014, 32 (02) : 253 - 258